BioMed Central | Articles which cite: Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Pulukuri SM, Estes N, Patel J, Rao JS Cancer Res 2007 Feb 1, 67:930-9 [PubMed Central] [PubMed] [Related articles]
2.	Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator. Pulukuri SM, Gorantla B, Rao JS J Biol Chem 2007 Dec 7, 282:35594-603 [PubMed Central] [PubMed] [Related articles]
3.	Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis. Dean JP, Nelson PS Br J Cancer 2008 Jan 29, 98:245-9 [PubMed Central] [PubMed] [Related articles]
4.	RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS J Biol Chem 2005 Oct 28, 280:36529-40 [PubMed Central] [PubMed] [Related articles]
5.	Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Kumar S, Weaver VM Cancer Metastasis Rev 2009 Jun, 28:113-27 [PubMed Central] [PubMed] [Related articles]
6.	Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. McCabe NP, De S, Vasanji A, Brainard J, Byzova TV Oncogene 2007 Sep 13, 26:6238-43 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 4 articles in BioMed Central

printer friendly

to [Help]